The Adjuvant Chemotherapy Trial of TS-1 for Colon Cancer (ACTS-CC) is a phase III trial designed to validate the non-inferiority of S-1 to UFT/leucovorin (LV) as postoperative adjuvant chemotherapy ...

UFT is an oral anticancer agent composed of tegafur and uracil at a 1 : 4 fixed molar ratio (Fujii et al, 1979). Although the clinical effectiveness of the single agent against advanced non-small-cell ...